1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

SPRB
Spruce Biosciences, Inc.US flagNASDAQ Capital Market
45.68
USD
+1.18
- -
62.67MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
10
5
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
10
5
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
-10
-5
- -
- Operating Expenses
10
13
29
42
47
62
61
37
+ Selling, General & Admin
2
2
6
11
12
13
15
17
+ Research & Development
8
11
24
31
35
49
46
20
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-10
-13
-29
-42
-47
-52
-56
-37
- Non-Operating (Income) Loss
- -
- -
- -
- -
-1
-4
-3
2
+ Interest Expense, Net
- -
- -
- -
- -
-1
-4
-3
-1
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
2
5
3
1
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
4
Pretax Income
-10
-13
-30
-42
-46
-48
-53
-39
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-10
-13
-30
-42
-46
-48
-53
-39
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-10
-13
-30
-42
-46
-48
-53
-39
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-10
-13
-30
-42
-46
-48
-53
-39
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-10
-13
-30
-42
-46
-48
-53
-39
EBIT
-10
-13
-29
-42
-47
-52
-56
-37
EBITDA
-10
-13
-29
-42
-47
-52
-56
-36
EBITDA Margin (%)
- -
- -
- -
- -
- -
-514.65
-1,142.44
- -
EBITA
-10
-13
-29
-42
-47
-52
-56
-37
Gross Margin (%)
- -
- -
- -
- -
- -
100
100
- -
Operating Margin (%)
- -
- -
- -
- -
- -
-515.34
-1,143.37
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-474.96
-1,079.94
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
1
1
1
Basic EPS, GAAP
-151.06
-107.35
-369.78
-135.78
-147.21
-93.32
-96.4
-50.83
Basic EPS from Cont Ops
-151.06
-107.35
-369.78
-135.78
-147.21
-93.32
-96.4
-50.83
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
1
1
1
Diluted EPS, GAAP
-151.06
-107.35
-369.78
-135.78
-147.21
-93.32
-96.4
-50.83
Diluted EPS from Cont Ops
-151.06
-107.35
-369.78
-135.78
-147.21
-93.32
-96.4
-50.83

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
5
5
160
92
84
102
44
52
+ Cash, Cash Equivalents & STI
4
4
157
89
79
96
39
49
+ Cash & Cash Equivalents
4
4
157
43
24
96
39
49
+ ST Investments
- -
- -
- -
46
55
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
3
3
5
6
5
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
2
35
2
2
1
1
+ Property, Plant & Equip, Net
- -
- -
2
1
1
1
1
1
+ Property, Plant & Equip
- -
- -
2
1
1
1
1
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
32
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
32
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
1
1
1
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
1
1
1
- -
- -
Total Assets
5
5
163
126
86
104
45
53
+ Payables & Accruals
2
2
6
7
9
15
12
8
+ Accounts Payable
2
2
4
3
1
3
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
4
8
11
11
7
+ ST Debt
- -
1
3
- -
2
2
2
- -
+ ST Borrowings
- -
1
3
- -
2
2
2
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
1
1
1
8
1
2
+ Deferred Revenue
- -
- -
- -
- -
- -
5
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
1
1
3
1
2
Total Current Liabilities
3
4
10
9
12
24
15
10
+ LT Debt
- -
3
4
6
5
3
1
- -
+ LT Borrowings
- -
3
2
5
3
2
- -
- -
+ LT Finance Leases
- -
- -
2
1
1
1
1
- -
+ Other LT Liabilities
20
28
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
20
28
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
20
31
4
6
5
3
1
- -
Total Liabilities
23
35
13
15
17
27
16
11
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
210
215
218
274
279
332
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
210
215
218
274
279
332
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-18
-31
-61
-103
-149
-197
-250
-289
+ Other Equity
- -
- -
- -
- -
-1
- -
- -
- -
Equity Before Minority Interest
-18
-31
149
111
68
77
29
43
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-18
-31
149
111
68
77
29
43
Total Liabilities & Equity
5
5
163
126
86
104
45
53
Shares Outstanding
- -
- -
- -
- -
- -
1
1
1
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
2
2
1
1
1
1
Net Debt
-4
1
-153
-38
-20
-93
-37
-49
Net Debt to Equity
23.1
-1.7
-102.17
-34
-28.58
-121.55
-128.4
-115.03
Tangible Common Equity Ratio
-372.82
-652.96
91.74
88.05
79.96
73.6
63.75
80.19
Current Ratio
1.76
1.08
16.43
10.36
6.72
4.18
2.9
5.17
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-10
-13
-30
-42
-46
-48
-53
-39
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
1
4
3
4
6
6
+ Stock-Based Compensation
- -
- -
1
4
4
5
5
3
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
- -
- -
4
+ Chg in Non-Cash Work Cap
1
- -
1
2
1
10
-9
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
- -
-3
- -
-1
-3
- -
2
+ Inc (Dec) in Accts Payable
2
- -
4
1
2
8
-4
-3
+ Inc (Dec) in Other
- -
1
- -
- -
- -
5
-5
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-9
-13
-28
-36
-42
-33
-56
-33
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
93
- -
- -
54
- -
50
+ Increase in Capital Stock
- -
- -
93
- -
- -
54
- -
50
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
-79
24
56
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
60
68
- -
- -
+ Inc in LT Investment
- -
- -
- -
-79
-37
-12
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-79
24
56
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
4
- -
- -
- -
-2
-2
-2
+ Cash From Debt
- -
4
- -
5
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
-5
- -
-2
-2
-2
+ Other Financing Activities
- -
8
88
- -
- -
-3
- -
-4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
12
181
1
- -
49
-2
43
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-9
- -
153
-114
-18
72
-58
10
EBITDA
-10
-13
-29
-42
-47
-52
-56
-36
EBITDA Margin (%)
- -
- -
- -
- -
- -
-514.65
-1,142.44
- -
Free Cash Flow
-9
-13
-28
-36
-42
-33
-56
-33
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-8
-28
-36
-42
-35
-58
-35
Free Cash Flow per Basic Share
-131.33
-103.52
-345.42
-115.48
-132.9
-64.82
-101.73
-43.47
Price/Free Cash Flow
- -
- -
-5.31
-2.91
-0.62
-3.39
-0.31
-2
Cash Flow to Net Income
0.87
0.96
0.93
0.85
0.9
0.69
1.06
0.86
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -